Predictive Oncology Inc (POAI) Stock

DelistedNasdaq: POAIPredictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies.

5.48
Final close · Dec 16, 2025

POAI is no longer traded. Predictive Oncology was delisted from the Nasdaq in December 2025.

Prices on this page are historical; the last trade was December 16, 2025 at $5.48.

Predictive Oncology stock price history

Split-adjusted closes, 2018–2025

POAI final trading statistics

Final close
$5.48
Final trading day
Dec 16, 2025
Market cap at delisting
$18.60M
Shares outstanding
3.39M
Final 52-week range
$0.66 – $16.54
Avg. volume (final 3 mo.)
104,345
All-time high (split-adj.)
$1000000.00 · Apr 2010
All-time low (split-adj.)
$4.26 · Dec 2025
Return since IPO
-100.0%
Beta
1.35
Book value / share
-$100.94
Price / book
-0.05
Final 52 wk
0.6616.54

Predictive Oncology earnings per share

Earnings per share

Predictive Oncology revenue & net income

RevenueNet income

Predictive Oncology annual financials

Fiscal yearRevenueNet incomeEPS
FY2024$1.62M-$12.2M-$2.44
FY2023$1.63M-$14.0M-$3.48
FY2022$1.51M-$25.7M-$0.35
FY2021$1.42M-$19.7M-$0.37
FY2020$1.25M-$25.9M-$5.15

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Predictive Oncology Inc

Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. Predictive Oncology Inc. has a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.

Predictive Oncology stock FAQ

What happened to Predictive Oncology stock?

Predictive Oncology stock was delisted from the Nasdaq. Its final close was $5.48 on December 16, 2025.

Is POAI stock still trading?

No. POAI was delisted from the Nasdaq in December 2025 and no longer trades on a U.S. exchange.

What was the last price of POAI stock?

POAI closed at $5.48 on its final trading day, December 16, 2025, for a market value of about $18.60M.

What were Predictive Oncology's revenue and earnings in its last full fiscal year?

Predictive Oncology reported revenue of $1.62M and net income of -$12.2M in fiscal 2024, its last full year as a public company.

When did Predictive Oncology go public?

Predictive Oncology Inc stock began trading on January 29, 2018.

Software - Infrastructure stocks to research

All Technology stocks →